BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26891684)

  • 21. Birth Weight- or Gestational Age-adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand.
    de Hora MR; Heather NL; Webster D; Albert BB; Hofman PL
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3390-e3399. PubMed ID: 34058748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementing steroid profiling by liquid chromatography-tandem mass spectrometry improves newborn screening for congenital adrenal hyperplasia in New Zealand.
    de Hora MR; Heather NL; Patel T; Bresnahan LG; Webster D; Hofman PL
    Clin Endocrinol (Oxf); 2021 Jun; 94(6):904-912. PubMed ID: 33471388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Twenty Years of Neonatal Screening for Congenital Adrenal Hyperplasia in North-Eastern Italy: Role of Liquid Chromatography-Tandem Mass Spectrometry as a Second-Tier Test.
    Cavarzere P; Camilot M; Palma L; Lauriola S; Gaudino R; Vincenzi M; Antoniazzi F; Teofoli F; Piacentini G
    Horm Res Paediatr; 2022; 95(3):255-263. PubMed ID: 35350013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of 11beta-hydroxylase deficiency detected in a newborn screening program by second-tier LC-MS/MS.
    Peter M; Janzen N; Sander S; Korsch E; Riepe FG; Sander J
    Horm Res; 2008; 69(4):253-6. PubMed ID: 18204274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advancement in steroid hormone analysis by LC-MS/MS in clinical routine diagnostics - A three year recap from serum cortisol to dried blood 17α-hydroxyprogesterone.
    Gaudl A; Kratzsch J; Ceglarek U
    J Steroid Biochem Mol Biol; 2019 Sep; 192():105389. PubMed ID: 31158444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of different preparation techniques of dried blood spot quality controls in newborn screening for congenital adrenal hyperplasia.
    Grecsó N; Zádori A; Baráth Á; Galla Z; Rácz G; Bereczki C; Monostori P
    PLoS One; 2021; 16(5):e0252091. PubMed ID: 34015037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of a liquid chromatography tandem mass spectrometry assay for eight adrenal C-21 steroids and pediatric reference data.
    Kulle AE; Welzel M; Holterhus PM; Riepe FG
    Horm Res Paediatr; 2013; 79(1):22-31. PubMed ID: 23328487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of adrenal cortical dysfunction by liquid chromatography-tandem mass spectrometry.
    Kao PC; Machacek DA; Magera MJ; Lacey JM; Rinaldo P
    Ann Clin Lab Sci; 2001 Apr; 31(2):199-204. PubMed ID: 11337910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal dexamethasone treatment in pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: effect on midgestational amniotic fluid steroid levels.
    Dörr HG; Sippell WG
    J Clin Endocrinol Metab; 1993 Jan; 76(1):117-20. PubMed ID: 8421074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An automated method on analysis of blood steroids using liquid chromatography tandem mass spectrometry: application to population screening for congenital adrenal hyperplasia in newborns.
    Dhillon K; Ho T; Rich P; Xu D; Lorey F; She J; Bhandal A
    Clin Chim Acta; 2011 Nov; 412(23-24):2076-84. PubMed ID: 21803033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitation of 17-OH-progesterone (OHPG) for diagnosis of congenital adrenal hyperplasia (CAH).
    Singh RJ
    Methods Mol Biol; 2010; 603():271-7. PubMed ID: 20077078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum steroid profiling for congenital adrenal hyperplasia using liquid chromatography-tandem mass spectrometry.
    Rossi C; Calton L; Hammond G; Brown HA; Wallace AM; Sacchetta P; Morris M
    Clin Chim Acta; 2010 Feb; 411(3-4):222-8. PubMed ID: 19931522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dried blood spot testing for seven steroids using liquid chromatography-tandem mass spectrometry with reference interval determination in the Korean population.
    Kim B; Lee MN; Park HD; Kim JW; Chang YS; Park WS; Lee SY
    Ann Lab Med; 2015 Nov; 35(6):578-85. PubMed ID: 26354345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of a precursor-to-product ratio in the evaluation of presumptive positives in newborn screening of congenital adrenal hyperplasia.
    Tieh PY; Yee JK; Hicks RA; Mao CS; Lee WN
    J Perinatol; 2017 Mar; 37(3):283-287. PubMed ID: 27929529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas].
    Gu X; Zhou J; Ye J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):16-8. PubMed ID: 11955341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Steroids Androstenedione, Dehydroepiandrosterone, 11-Deoxycortisol, 17-Hydroxyprogesterone, and Testosterone.
    Munar A; Clinton Frazee C; Garg U
    Methods Mol Biol; 2022; 2546():451-457. PubMed ID: 36127612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous determination of 17alpha-hydroxypregnenolone and 17alpha-hydroxyprogesterone in dried blood spots from low birth weight infants using LC-MS/MS.
    Higashi T; Nishio T; Uchida S; Shimada K; Fukushi M; Maeda M
    J Pharm Biomed Anal; 2008 Sep; 48(1):177-82. PubMed ID: 18571354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional glucocorticoid receptor gene variants do not underlie the high variability of 17-hydroxyprogesterone screening values in healthy newborns.
    Schreiner F; Tozakidou M; Maslak R; Holtkamp U; Peter M; Gohlke B; Woelfle J
    Eur J Endocrinol; 2009 Apr; 160(4):667-73. PubMed ID: 19174530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An LC-MS/MS method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronism.
    Peitzsch M; Dekkers T; Haase M; Sweep FC; Quack I; Antoch G; Siegert G; Lenders JW; Deinum J; Willenberg HS; Eisenhofer G
    J Steroid Biochem Mol Biol; 2015 Jan; 145():75-84. PubMed ID: 25312486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LC-MS/MS based determination of basal- and ACTH-stimulated plasma concentrations of 11 steroid hormones: implications for detecting heterozygote CYP21A2 mutation carriers.
    Kulle AE; Riepe FG; Hedderich J; Sippell WG; Schmitz J; Niermeyer L; Holterhus PM
    Eur J Endocrinol; 2015 Oct; 173(4):517-24. PubMed ID: 26315375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.